September FDA news in review

Welcome to the first installment of "FDA News in Review," where each month we'll take a look at the agency's latest decision, approvals, warnings and recalls. We hope this feature will help you keep up on FDA trends--and catch up on stories you may have missed.

One of the top stories out of the FDA this month was the agency's push to fill 1,300 new positions. The new hires include chemists, biologists and microbiologists, many of whom will be assigned to the CDER. Overall, the agency is increasing its workforce by about 10 percent. And while the FDA was light on approvals this month, it was certainly busy monitoring drug safety. The agency announced that it will now release a quarterly list of drugs under investigation due to adverse events. The nature of the complaints will be included in the report, but the number of complaints won't be.